SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-068241
Filing Date
2013-09-05
Accepted
2013-09-05 16:58:58
Documents
5
Period of Report
2013-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-20284_18k.htm 8-K 39124
2 EX-10.1 a13-20284_1ex10d1.htm EX-10.1 70602
3 EX-10.2 a13-20284_1ex10d2.htm EX-10.2 17834
4 EX-99.1 a13-20284_1ex99d1.htm EX-99.1 10895
5 GRAPHIC g202841mmi001.gif GRAPHIC 4816
  Complete submission text file 0001104659-13-068241.txt   146607
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 131080925
SIC: 2834 Pharmaceutical Preparations